Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. SOLUBACTER (triclocarban)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

SOLUBACTER (triclocarban)

Medicine - Posted on Jun 30 2004 - Updated on Jun 12 2019
Active substance (DCI)
  • triclocarban
history (1)
  • 6/30/04

    SOLUBACTER 1 %, solution pour application locale flacons de 150 et de 400 mL (Codes CIP : 311 781 4 (flacon de 150 mL) et 315 397 4 (flacon de 400 mL))

    SOLUBACTER 1 %, solution pour application locale flacons de 150 et de 400 mL (Codes CIP : 311 781 4 (flacon de 150 mL) et 315 397 4 (flacon de 400 mL))
    icône flèche
Technical information
Manufacturer
BOOTS HEALTHCARE
Presentation

SOLUBACTER 1 %, solution pour application locale
flacon de 150 mL - Code CIP : 311 781-4
flacon de 400 mL - Code CIP : 315 397-4

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
PaAxJ0bJ17P0S1fs